AngioDynamics, Inc. (ANGO) is expected to report earnings for the quarter ending November 30, 2025, with a consensus forecast of -$0.10 per share, a 150.00% decrease from last year. ANGO has consistently beat expectations in the past year, with the highest beat of 28.57% in the 3rd quarter. Zacks Investment Research reports a 2026 Price to Earnings ratio of -45.29 for ANGO, compared to an industry ratio of 1.70. Check out Nasdaq’s Earnings Calendar for more upcoming reports.

Read more at Nasdaq.: Pre-Market Earnings Report for January 6, 2026 : ANGO